Stocks
GlaxoSmithKline (GSK) Net profit US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net profit, £ | ? | 4 385 000 000 | 4 921 000 000 | 4 921 000 000 | 4 928 000 000 | 4 928 000 000 | 3 210 000 000 | ||
| Changes by years, y/y, % | 0% | +12% | 0% | +0% | 0% | +6.3% | |||
GlaxoSmithKline. Net profit US GAAP, £
GlaxoSmithKline. Net profit US GAAP, changes, %
GlaxoSmithKline. Net profit US GAAP, sum by quarters, £
GlaxoSmithKline (GSK) Net profit US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| Net profit, £ | ? | 1 624 000 000 | 1 464 000 000 | 350 000 000 | 350 000 000 | 1 046 000 000 | 3 210 000 000 | |
| Changes by years, y/y, % | +94% | +88% | -76% | -76% | -30% | |||
| Changes by quarters, q/q, % | 0% | -10% | -76% | 0% | +199% | |||
